Page last updated: 2024-11-07

aldosterone and Cardio-embolic Stroke

aldosterone has been researched along with Cardio-embolic Stroke in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Primary aldosteronism (PA) is the most common cause of secondary hypertension, and patients are at an increased risk of atrial fibrillation (AF) and stroke."1.72Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation. ( Aw, TC; Chai, SC; Fones, S; Foo, RSY; Lai, J; Mamauag, MJB; Nguyen, V; Ong, L; Puar, TH; Saffari, SE; Tu, TM; Zhang, M, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Nguyen, V1
Tu, TM1
Mamauag, MJB1
Lai, J1
Saffari, SE1
Aw, TC1
Ong, L1
Foo, RSY1
Chai, SC1
Fones, S1
Zhang, M1
Puar, TH1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Prevalence of Primary Aldosteronism in Patients With Stroke[NCT03789357]300 participants (Actual)Observational2018-05-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for aldosterone and Cardio-embolic Stroke

ArticleYear
Primary Aldosteronism More Prevalent in Patients With Cardioembolic Stroke and Atrial Fibrillation.
    Frontiers in endocrinology, 2022, Volume: 13

    Topics: Aldosterone; Atrial Fibrillation; Embolic Stroke; Humans; Hyperaldosteronism; Hypertension; Renin; S

2022